BNET Industries

Embrex Inc.

is in the Pharma Industry

Last Fiscal Year Sales:$52.5M
  • Private
  • US
Dow Jones Description

The egg arrived and then came Embrex. Founded in 1985 and headquartered in Durham, NC, Embrex Inc. develops biological products for poultry, domestically as well as internationally. The company markets the Inovoject system, which can process up to 70,000 eggs per hour, therefore abolishing the need for manual injection of vaccines. The company also makes poultry vaccines, such as Newplex and Bursaplex, in addition to research and development services. It has annual revenue of over $52 million and has about 300 employees. In April 2006, USDA granted product and manufacturing facility licenses to produce and sell Inovocox(TM), in ovo coccidiosis vaccine.

President & CEO
Randall L. Marcuson
Number of Employees 309
Contact Information

1040 Swabia Ct

PO Box 13989

Durham, North Carolina 27703-8481

www.embrex.com

1 919 941 5185

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Reportlinker Adds Veterinary Vaccines - A World Market Analysis

    11/25/09 - Merger / Acquisition - View Story

News & Analysis

embrex inc. - All News and Analysis

  • Embrex.(TRIANGLE)(Brief article)

    - 2006-07-01

    Durham-based Embrex, which designs machines that vaccinate poultry inside the egg, won U.S. Department of Agriculture approval to make and sell Inovocox, a vaccine that combats a digestive disorder. Embrex also received USDA approval for its Inovocox factory in Scotland County. The factory employs about 20...

    Tags: Embrex Inc.

  • Embrex.(TRIANGLE)(Brief article)

    - 2006-07-01

    Durham-based Embrex, which designs machines that vaccinate poultry inside the egg, won U.S. Department of Agriculture approval to make and sell Inovocox, a vaccine that combats a digestive disorder. ... Durham-based Embrex, which designs machines that vaccinate poultry inside the egg, won U.S. Department of Agriculture...

    Tags: U.S. Department of Agriculture

  • Embrex Inc

    - 2006-05-01

    Embrex Inc. of Research Triangle Park has received federal approval to manufacture its poultry vaccine Inovocox at the firm's new $15 million production facility in Scotland County.

    Tags: Embrex Inc.

  • Embrex Announces First Quarter 2006 Financial Results Release and Conference Call

    - 2006-04-28

    RESEARCH TRIANGLE PARK, N.C. -- EmbrexR, Inc., The In Ovo CompanyR, (Nasdaq:EMBX) announced Embrex management intends to file its First Quarter 2006 Form 10-Q and issue its financial press release on Monday, May 8, 2006. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these financial...

    Tags: Randall

  • Embrex Announces Fourth Quarter, Year-End 2005 Financial Results Release and Conference Call

    - 2006-02-16

    RESEARCH TRIANGLE PARK, N.C. -- EmbrexR, Inc., The In Ovo CompanyR, (Nasdaq:EMBX) announced Embrex management intends to file its Year-End and Fourth Quarter 2005 Form 10-K and issue its financial press release on Wednesday, March 8, 2006. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss...

    Tags: Embrex Inc.

Decision Makers

Name (plus bio) Position
Randall L. Marcuson President & CEO
Brian Hrudka Vice President, Marketing & Latin America
Catherine Ricks Vice President, Res & Development
David M. Baines Vice President, Sales, Global
Don T. Seaquist Vice President, Finance, Administration
Ellen Moore Vice President, Investor Relations & Communications
Joseph P. O'Dowd Vice President, Product Development
Robin Shyr Vice President
David Shapiro Senior Director, Global Veterinary Services
Phoebe Johnson Manager, Marketing Services
Gerald Roach General Counsel
John E KIein

Board of Directors

Name (plus bio) Position
Harold V Smith Chairman
C. Daniel Blackshear Board of Directors
C. Daniel Seaquist Board of Directors
David L. Castaldi Board of Directors
Ganesh M. Kishore Board of Directors
John E. Klein Board of Directors

Organization Position Status
Embrex Inc. President & CEO Current
Embrex Inc. President & CEO Current

Organization Position Status
Embrex Inc. Vice President, Marketing & Latin America Current
Novartis AG Brand Manager Former
The University of Western Ontario B.S. degree in biochemistry and an MBA Former

Organization Position Status
Embrex Inc. Vice President, Res & Development Current
Immunobiosciences Inc. Vice President of Research and Development at Embrex Current
Immunobiosciences Inc. Board of Directors Current
North Carolina State University Adjunct Professor Former
Michigan State University Ph.D. In Nutritional Biochemistry Former
King's College Ph.D. In Nutritional Biochemistry Former
University of London M.S. in plant physiology Former
King's College B.Sc. In Botany Former

Organization Position Status
Embrex Inc. Vice President, Sales, Global Current
University of London Ph.D. degree in entomology Former
Reading University B.Sc. degree in zoology Former

Organization Position Status
Embrex Inc. Vice President, Finance, Administration Current
Embrex Inc. Vice President, Finance, Admin Current

Organization Position Status
Embrex Inc. Vice President, Investor Relations & Communications Current
Tufts University bachelor's degree in political science Former

Organization Position Status
Embrex Inc. Vice President, Product Development Current
California State University B.A. in Asian Studies Former

Organization Position Status
Embrex Inc. Vice President Current

Organization Position Status
Embrex Inc. Senior Director, Global Veterinary Services Current
Embrex Inc. Senior Director, Global Veterinary Services Former

Organization Position Status
Embrex Inc. Manager, Marketing Services Current

Organization Position Status
Embrex Inc. General Counsel Current

Organization Position Status
Embrex Inc. Current
Washington University Executive Vice Chancellor of Administration Former
Bunge Limited Former
Sullivan & Cromwell LLP Former

Organization Position Status
Lasys, Inc President, CEO Current
Sterling Drug Current
Abbott Laboratories Current
Embrex Inc. Chairman Current
Eco-Gen, Ltd Chairman Current
Lasys, Inc Chairman Current
Ensys Chairman Current
University of California, Los Angeles B.S. Degree Former

Organization Position Status
Embrex Inc. Board of Directors Current
The University of Georgia M.S. degree in Food Science and Management Former

Organization Position Status
Embrex Inc. Board of Directors Current

Organization Position Status
Embrex Inc. Board of Directors Current
Biolex, Inc. Board of Directors Current
Baxter International Inc. Former
Genzyme Corporation Former
University of Notre Dame B.A. degree in business Former

Organization Position Status
Mlscf CEO Current
Burrill & Company Managing Director Current
Embrex Inc. Board of Directors Current
Monsanto Company Chief Biotechnologist Former
DuPont Qualicon Vice President, Tech, Chief BioTech Officer Former
E.I. du Pont de Nemours & Company Vice President, Technology, Agriculture & Nutrition Former
Monsanto Company Distinguished Science Fellow Former
Indian Institute of Science PhD In Biochemistry Former
University of Mysore degrees in biochemistry, physics and chemistry Former

Organization Position Status
Embrex Inc. Board of Directors Current

Executive News

  • Joseph O'Dowd Joins SteriFx Inc. Global sales, marketing and R&D professional to bolster pathogen control leader.

    Yahoo! Canada - 9/02/09 - View Story

  • Joseph O'Dowd Joins SteriFx Inc.

    Interest!ALERT - 9/02/09 - View Story

  • Joseph O'Dowd Joins SteriFx Inc.

    NewsBlaze - 9/02/09 - View Story

Presented by American Express